Jones Trading Maintains Buy on Trevi Therapeutics, Raises Price Target to $28

Jones Trading analyst Debanjana Chatterjee maintains Trevi Therapeutics (NASDAQ:TRVI) with a Buy and raises the price target from $24 to $28.